105
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEImagining Diagnosis Prognosis

Glutathione-S-Transferase-Pi Expression in Early Breast Cancer: Association With Outcome and Response to Chemotherapy

, , , , , , , , & show all
Pages 554-559 | Published online: 08 Mar 2010

REFERENCES

  • Armstrong, R.N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 1997, 10, 2–18.
  • Perry, R.R.; Mazetta, J.A.; Levin, M.; Barranco, S.C. Glutathione levels and variability n breast tumors and normal tissue. Cancer 1993, 72, 783–787.
  • Williams, J.A.; Phillips, D.H. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res 2000, 60, 4667–4677.
  • Gilbert, L.; Elwood, L.J.; Merino, M., A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993, 11, 49–58.
  • Colovai, A.I.; Stoica, A.; Cinca, S.A., Glutathione S-transferase activity in human breast tumors. Neoplasma 1992, 39, 249–254.
  • Arai, T.; Miyoshi, Y.; Kim, S.J.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 2006, 100, 169–176.
  • Peters, W.H.; Roelofs, H.M.; van Putten, W.L.; Jansen, J.B.; Klijn, J.G.; Foekens, J.A. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 1993, 68, 86–92.
  • Huang, J.; Tan, P.H.; Thiyagarajan, J.; Bay, B.H. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 2003, 16, 558–565.
  • Perquin, M.; Oster, T.; Maul, A.; Froment, N.; Untereiner, M.; Bagrel, D. The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J Cancer Res Clin Oncol 2001, 127, 368–374.
  • Montano, M.M.; Deng, H.; Liu, M.; Sun, X.; Singal, R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 2004, 23, 2442–2453.
  • Dawling, S.; Hachey, D.L.; Roodi, N.; Parl, F.F. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chem Res Toxicol 2004, 17, 1258–1264.
  • Schiff, R.; Reddy, P.; Ahotupa, M., Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Nat Cancer Inst 2000, 92, 1926–1934.
  • Soubeyran, I.; Quenel, N.; Coindre, J.M., pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. Br J Cancer 1996, 74, 1120–1125.
  • MacGrogan, G.; Mauriac, L.; Durand, M., Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. Br J Cancer 1996, 74, 1458–1465.
  • Kim, R.; Hirabayashi, N.; Nishiyama, M.; Saeki, S.; Toge, T.; Okada, K. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin. Anticancer Res 1991, 11, 429–431.
  • Su, F.; Hu, X.; Jia, W.; Gong, C.; Song, E.; Hamar, P. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. J Surg Res 2003, 113, 102–108.
  • Wright, C.; Cairns, J.; Cantwell, B.J., Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br J Cancer 1992, 65, 271–274.
  • Ali-Osman, F.; Brunner, J.M.; Kutluk, T.M.; Hess, K. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin Cancer Res 1997, 3, 2253–2261.
  • Silvestrini, R.; Veneroni, S.; Benini, E., Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Nat Cancer Inst 1997, 89, 639–645.
  • Haas, S.; Pierl, C.; Harth, V., Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Int J Cancer 2006, 119, 1785–1791.
  • Moureau-Zabotto, L.; Ricci, S.; Lefranc, J.P., Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients. Br J Cancer 2006, 94, 473–480.
  • Buser, K.; Joncourt, F.; Altermatt, H.J.; Bacchi, M.; Oberli, A.; Cerny, T. Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Ann Oncol 1997, 8, 335–341.
  • Adler, V.; Yin, Z.; Fuchs, S.Y., Regulation of JNK signaling by GSTp. EMBO J 1999, 18, 1321–1334.
  • Elsby, R.; Kitteringham, N.R.; Goldring, C.E., Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem 2003, 278, 22243–22249.
  • Ruscoe, J.E.; Rosario, L.A.; Wang, T., Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 2001, 298, 339–345.
  • Shen, H.; Kauvar, L.; Tew, K.D. Importance of glutathione and associated enzymes in drug response. Oncol Res 1997, 9, 295–302.
  • Cairns, J.; Wright, C.; Cattan, A.R., Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 1992, 166, 19–25.
  • Singh, S.V.; Brunnert, S.R.; Roberts, B.; Krishan, A. Differential expression of glutathione S-transferase, glutathione peroxidase and glutathione reductase in normal and malignant human breast tissues. Cancer Lett 1990, 51, 43–48.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.